A randomised placebo-controlled trial of cannabidiol to treat severe behavioural problems in children and adolescents with intellectual disability.
Kids Research is looking for children
6 to 18 years to take part in a clinical trial looking at the effectiveness of cannabidiol (CBD) for reducing severe behaviour problems in children and adolescents with Intellectual Disability (ID).
Severe behaviour problems, like aggression and self-injurious behaviours, can have a major impact on families. Current drugs used to treat behaviour problems are not always helpful and can cause side-effects.
This study is testing a type of medical cannabis called cannabidiol (CBD) as a treatment for severe behavioural problems in children with ID. CBD is a legal cannabis extract and does not cause a “high”, which can happen with the other main chemical in cannabis, THC. CBD may be helpful in improving behaviour and may also have fewer side effects than existing medications.
Eligible children will be randomised to receive either oral CBD oil (10mg/kg/day) or placebo over 10 weeks.
The trial involves 2 clinic visits and 2 blood tests, and 5 telehealth appointments, over a total period of 14 weeks (including screening, up-titration, down-titration, and 4-week follow-up period). Reimbursement will be provided for travel and parking.
This study has been approved by SCHN Governance STE00703.
To find out more, contact:
Julie Ha
Email: Julie.Ha1@health.nsw.gov.au
Phone: 0429268770
Open the poster here